Menu
Back to Journals » Therapeutics and Clinical Risk Management » Machine Learning in the Realm of Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2348)
- Volume 20, 2024 (40)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Journal Articles:
- Lymphoproliferation at the crossroad between hematology and immunology: molecular and clinical implications (1)
- Anticholinergic Therapies for the Treatment of Asthma (7)
Machine Learning in the Realm of Therapeutics and Clinical Risk Management
Machine Learning (ML) and healthcare is one of the most interesting research topics in modern medicine, giving the opportunity to improve patient care, diagnosis, personalized treatment and risk management. The fast evolving of data analytics can improve the vast amount of health data analysis, aiming to improve outcomes, reduce costs and personalize healthcare. Giving the increasing use of healthcare systems that face aging populations, chronic disease and cost effective treatments, ML integration offers a hope, driving innovations of clinical care, research, and public health.